Le Lézard
Classified in: Health

Lift&Co. Expo Welcomes 10K+: Canada's No. 1 Cannabis & Psychedelics Conference is Back & Better Than Ever!

Toronto, ON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Exciting! Engaging! Enlightening! Lift&Co. Expo returned to Toronto last week, with exclamations aplenty. After an anticipation-building hiatus, Canada's no. 1 cannabis and psychedelics conference and trade show treated thousands to surprises and a-ha moments, levelling-up its signature experience with many forward-thinking new features.

Kicking off Day 1 on November 18, the event's fan-favourite full-day conference did not disappoint. The 2021 Lift Cannabis Business Conference gathered Canada's top business leaders, innovators, and policymakers for a veritable master class in the cannabis industry. Day 2 on November 19 brought the debut of the Lift Psychedelics Business Summit, an in-depth exploration of dynamic new psychedelics intel and advances. The Lift&Co. Expo Industry & Consumer Days trade show, November 19 ? 21, rounded out the schedule, including hundreds of up-and-coming exhibitors and dozens of special presentations.

Lift&Co. Expo 2021 Highlights included:

"This year's Lift&Co. Expo exceeded our expectations across the board," says Shawn Pierce, President of MCI Events. "As I walked the expo floor, talking with so many business owners and guests, I was inspired by the sense of camaraderie and positivity within the Lift&Co. community. It was a privilege to bring this beloved event back, and better than ever before. With thanks to the city of Toronto and the hard-working team members who made this show possible, we look forward to seeing you all again next year."

Save The Date!
Lift&Co. Expo
Toronto, Ontario
May 12-15, 2022


MCI is the global leader in engaging and activating audiences. Our business is founded on a simple human insight:?When people come together, magic happens. Since 1987, we have been bringing people together through?inspiring meetings, events, congresses and associations or community management. MCI helps organizations harness the power of community by applying our strategic engagement and activation solutions to build unforgettable online and offline experiences that foster change, inspire, educate, and enhance business performance. MCI is an independently owned company headquartered in Geneva, Switzerland, and boasts a global presence with 2,500+ professionals in 61?offices and 31 countries, who work with clients across Europe, the Americas, Asia-Pacific, India, and the Middle East.?Visit us at?wearemci.com?or?Twitter,?LinkedIn,?Facebook.


MVP Education, LLC is an equity investor who partners with associations, event owners and license owners to accelerate the growth, innovation, and impact of your events.


These press releases may also interest you

at 16:20
Oragenics, Inc. ("Oragenics" or the "Company"), a biotechnology company dedicated to fighting infectious diseases, announces the award of a grant from CQDM, a Canadian bioresearch consortium, for the collaborative development of a variant-agnostic...

at 16:15
GE HealthCare Technologies Inc. (the "Company" or "GE HealthCare") announced today the launch of a secondary underwritten public offering (the "Offering") of 25,000,000 shares of its common stock (the "GEHC Shares"). GE HealthCare is not selling any...

at 16:10
Viridian Therapeutics, Inc. (the "Company" or "Viridian"), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent...

at 16:10
VolitionRx Limited ("Volition"), a multi-national epigenetics company, announced today the closing of its previously announced underwritten public offering of its common stock generating gross proceeds to Volition from the offering of approximately...

at 16:10
On Lok is partnering with San Francisco Health Plan (SFHP) to provide Enhanced Care Management (ECM) to SFHP members starting May 1. A new Medi-Cal benefit offered through CalAIM (California Advancing and Innovating Medi-Cal), ECM provides intensive...

at 16:05
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that management will present a company overview at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023 at 8:00 am PT (11:00 am ET)...

News published on and distributed by: